Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1990-07-12
1992-08-04
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 27, 536 28, 536 29, 530351, A61K 3170, C07H 2100
Patent
active
051359170
ABSTRACT:
Disclosed are oligonucleotide compounds that inhibit interleukin receptor expression when administered to a human subject. Also disclosed are pharmaceutical compositions and methods for inhibiting human interleukin receptor expression.
REFERENCES:
patent: 4689320 (1987-08-01), Akira
patent: 5075222 (1991-12-01), Hannum et al.
Sims, J. E. et al., cDNA Expression Cloning of the I1-1 Receptor a Member of the Immunoglobulin Superfamily, Sci. 241:585-590 (1988).
Sims J. E. et al., Cloning the Interleukin 1 Receptor From Human T Cells, Proc. Natl. Acad. Sci. USA 86:8946-8950 (1989).
Sumikawa K. and R. Miledi, Receptor of Nicotinic Acetylcholin Receptor Expressions by Antisense RNA and an Oligonucleotide, Proc. Natl. Acad. Sci. USA 85:1302-1306 (1988).
Zheng, H. et al., Specific Inhibition of Cell-Surface T-Cell Receptor Expression by Antisense Oligodeoxynucleotides and its Effect on the Production of an Antigen-specific Regulator T-Cell Factor, Proc. Natl. Acad. Sci. as USA 86:3758-3762 (1989).
Chua, A. O. and Gubler, U., Sequence of the cDNA For The Human Fibroblast Type Interleukin-1 Receptor, Nucleic Acid Res. 17:10114 (1989).
Cohen, J. S., Designing Antisense Oligonucleotides as Pharmaceutical Agents, Trends in Pharmacol. Sci.: 10(11)435-437 (1989).
Stec. W. J. et al., Automated Solid-Phase Synthesis, Separation, and Stereochemistry of Phosphorothioate Analogues of Oilgodeoxyribonucleotides, J. Am. Chem. Soc. 106:6077-6079 (1984).
Adams, S. P. et al., Hindered Dialkylamino Nucleoside Phosphate Reagents in the Synthesis of Two DNA 51-MERS, J. Am. Chem. Soc. 105:661-663 (1983).
Agarwal, K. L. and Riftina, F., Synthesis and Enzymatic Properties of Deoxyribooligonucleotides Containing Methyl and Phenylphosphonate Linkages, Nucl. Acids Res. 6(9):3009-3024 (1979).
Synthesis 1(1) 1988, published by Synthecell Corp., Gaithersburg, Md.
Marcus-Sekura, C. J. Techniques for Using Antisense Oligodeoxyribonucleotides to Study Gene Expression, Anal. Biochem. 172:289-295 (1988).
Weintraub, H. M., Antisense RNA and DNA, Sci. AM. pp. 40-46 (1990).
Van Der Krol, A. R., et al., Modulation of Eukaryotic Gene Expression by Complimentary RNA or DNA Sequences, BioTechniques 6(10):958-976 (1988).
Crane L. Eric
Fabiano Vincent L.
Nova Pharmaceutical Corporation
Rollins John W.
LandOfFree
Interleukin receptor expression inhibiting antisense oligonucleo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin receptor expression inhibiting antisense oligonucleo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin receptor expression inhibiting antisense oligonucleo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-778401